[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fnIeNWt6drO6sRHjIwIN0pQaUM5EFhbf8byQTt_UqFE4":8,"$fy-ctZks9nj2P5QseRHKS6AnukzL9tI0tj7IdSwrLnnU":55,"$f5ECO7ppZvOdwTMo-yWIkqlzTUqK2ng2YDd3D-P0HLxc":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},67356,867287,[],"https://cdn.yishi-tong.com/console/store-unknown/uF7OMd0P_hB1LaAPsAH23kXFsYY6stA4.png","侯信明","聊城市第二人民医院","甲状腺乳腺外科","主治医师",111,0,"乳腺癌Luminal A型化疗方案实用用药指南 🎗️","","https://ystcdn.venuertc.com/venue/AI/9fb14c33-235e-439f-ad43-03b1b2f673fb.jpg","\u003Cdiv class=\"drugguide-material-container\">\n  \u003Cdiv class=\"drugguide-material-header\">\n    \u003Ch2 id=\"material_title\" class=\"drugguide-material-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">乳腺癌Luminal A型化疗方案实用用药指南 🎗️\u003C/h2>\n    \u003Cdiv class=\"drugguide-material-intro\">\n      \u003Cp>说起乳腺癌辅助化疗，不少人关注药物如何选用，其实关键在于安全和规范。蒽环类药、紫杉醇制剂等，是Luminal A型乳腺癌化疗常见选择。今天，我们就带大家梳理7个非常重要的用药细节，包括药物成分、服用方法、剂型特点、不良反应识别、相互作用、储存要求以及特殊情况处理，让大家用药时更有底气，减少风险。\u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \u003C!-- 01 药物成分和剂型选用要点 -->\n  \u003Csection class=\"drugguide-material-section drugguide-section-bg1\">\n    \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">01. 药物成分和剂型选用要点 💊\u003C/h2>\n    \u003Cdiv class=\"drugguide-material-content\">\n      \u003Cul>\n        \u003Cli>蒽环类（如多柔比星）、紫杉醇类（如白蛋白结合型紫杉醇、脂质体紫杉醇）是辅助化疗的主要药物成分。\u003C/li>\n        \u003Cli>不同制剂对溶剂和给药方式敏感。传统紫杉醇需要溶解于特殊载体，部分新型制剂如白蛋白结合型和脂质体紫杉醇则溶解性好，减少溶剂相关反应。\u003C/li>\n        \u003Cli>注射剂型需由专业人员静脉滴注，不能自行调整剂量或方法。\u003C/li>\n        \u003Cli>在临床实践中，患者更容易耐受脂质体紫杉醇，过敏反应显著减少（文献：Gradishar WJ, et al., \"Polymer-drug conjugates as anticancer therapeutics\", J Clin Oncol, 2014）。\u003C/li>\n        \u003Cli>正确做法：服用/使用前一定核对药品名称、剂型和批号，避免以次充好或误用。\u003C/li>\n      \u003C/ul>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 02 使用方法和给药周期 -->\n  \u003Csection class=\"drugguide-material-section drugguide-section-bg2\">\n    \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">02. 使用方法和给药周期⏳\u003C/h2>\n    \u003Cdiv class=\"drugguide-material-content\">\n      \u003Cul>\n        \u003Cli>所有辅助化疗方案均为静脉输注，须在医疗机构完成，严禁自购自用。\u003C/li>\n        \u003Cli>每个化疗周期通常间隔21天，剂量和时间由医生根据患者体重和药品规格调整。\u003C/li>\n        \u003Cli>化疗当天避免剧烈活动，确保充分休息。\u003C/li>\n        \u003Cli>如遇特殊事件（如注射当天身体不适），必须报告医师，由专业人员评估是否调整用药时间。\u003C/li>\n        \u003Cli>按照说明：“部分制剂如白蛋白结合型紫杉醇，给药速度可较传统制剂快，输注时间一般为30-60分钟。”（参考文献：O'Shaughnessy J, \"Weekly nanoparticle albumin-bound paclitaxel in metastatic breast cancer\", Cancer, 2015）。\u003C/li>\n      \u003C/ul>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 03 剂型特点和实际使用技巧 -->\n  \u003Csection class=\"drugguide-material-section drugguide-section-bg3\">\n    \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">03. 剂型特点与实际使用技巧 🧃\u003C/h2>\n    \u003Cdiv class=\"drugguide-material-content\">\n      \u003Cul>\n        \u003Cli>蒽环类及紫杉醇类皆为注射剂型，不存在口服片，家庭无法自行操作。\u003C/li>\n        \u003Cli>部分新型制剂无需使用多余溶剂，可减少输液反应。\u003C/li>\n        \u003Cli>脂质体紫杉醇与白蛋白结合型紫杉醇注射液要求当日现配，存放温度控制在2-8℃，室温不得超过1小时。\u003C/li>\n        \u003Cli>药物溶液外观应澄清无颗粒，发现变色、悬浮物或沉淀应弃用。\u003C/li>\n        \u003Cli>正确做法：用药前要求护士再次核对姓名、药名，严格遵照科室用药流程。\u003C/li>\n      \u003C/ul>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 04 药物相互作用与合并用药注意事项 -->\n  \u003Csection class=\"drugguide-material-section drugguide-section-bg4\">\n    \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">04. 药物相互作用和合并用药 🚦\u003C/h2>\n    \u003Cdiv class=\"drugguide-material-content\">\n      \u003Cul>\n        \u003Cli>蒽环类和紫杉醇类药物与以下药物有明显相互作用：\n          \u003Cul>\n            \u003Cli>细胞毒性药物联合时须严格分开不同输液管。\u003C/li>\n            \u003Cli>肝药酶抑制剂（如某些抗生素、抗真菌药）会升高化疗药品血药浓度，增加毒性。\u003C/li>\n            \u003Cli>有证据显示葡萄柚汁可能影响紫杉醇代谢（文献：van Erp NP et al, \"Effect of grapefruit juice on the pharmacokinetics of paclitaxel\", Cancer Chemother Pharmacol, 2004）。\u003C/li>\n            \u003Cli>不建议同时服用含维生素K或血液稀释剂，应提前告知医生。\u003C/li>\n            \u003Cli>内分泌药（如他莫昔芬）结合用药时，需要医生综合调整顺序。\u003C/li>\n          \u003C/ul>\n        \u003C/li>\n        \u003Cli>正确做法：服用任何新药或健康补品前，需与医生或药师确认。务必避免私自合并其他药物。\u003C/li>\n      \u003C/ul>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 05 常见不良反应及处理方法 -->\n  \u003Csection class=\"drugguide-material-section drugguide-section-bg5\">\n    \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">05. 常见不良反应识别与处理 🩺\u003C/h2>\n    \u003Cdiv class=\"drugguide-material-content\">\n      \u003Cul>\n        \u003Cli>蒽环类药物可能导致脱发、恶心、呕吐等，少数可致心脏功能变化，需密切监测心电图。\u003C/li>\n        \u003Cli>紫杉醇类通常出现周围神经感觉异常，偶见过敏反应，新型制剂如脂质体紫杉醇发生率明显下降。\u003C/li>\n        \u003Cli>临床研究显示：脂质体紫杉醇过敏反应发生率低于2%（Gradishar WJ, et al., J Clin Oncol, 2014）。\u003C/li>\n        \u003Cli>如出现输液反应（皮肤瘙痒、呼吸不畅），需立即告知护士并停止输注。\u003C/li>\n        \u003Cli>恶心呕吐为常见反应，大多可用预防性止吐药缓解，不可擅自增加止吐药剂量。\u003C/li>\n        \u003Cli>正确做法：每次化疗前提前告知以往不良反应，化疗中主动沟通异常感受，及时采取措施。\u003C/li>\n        \u003Cli>案例：有位患者第8周期使用脂质体紫杉醇后，仅出现轻微恶心，通过医生指导用药，未见严重副作用。\u003C/li>\n      \u003C/ul>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 06 储存要求及有效期管理 -->\n  \u003Csection class=\"drugguide-material-section drugguide-section-bg6\">\n    \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">06. 储存方式与有效期管理 🧊\u003C/h2>\n    \u003Cdiv class=\"drugguide-material-content\">\n      \u003Cul>\n        \u003Cli>所有注射制剂应存放于2-8℃冷藏环境，避免光照。\u003C/li>\n        \u003Cli>开启后需在规定时间内用完，如脂质体紫杉醇注射液开瓶后需2小时内使用。\u003C/li>\n        \u003Cli>药品有效期由包装上批号和日期决定，绝不使用过期制剂。\u003C/li>\n        \u003Cli>发现药品外观异常（沉淀、变色）或包装损坏应立即报护士处理。\u003C/li>\n        \u003Cli>家庭不可自行储存此类药物，如出现手误拿错药物，应及时更换，不可迁就。\u003C/li>\n      \u003C/ul>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 07 漏服与过量处理办法 -->\n  \u003Csection class=\"drugguide-material-section drugguide-section-bg7\">\n    \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">07. 漏服/过量使用处理方法 🆘\u003C/h2>\n    \u003Cdiv class=\"drugguide-material-content\">\n      \u003Cul>\n        \u003Cli>辅助化疗药必须由医护团队操作，患者无需自行处理漏服。\u003C/li>\n        \u003Cli>如出现漏用某一周期，需由主诊医生重新评估，绝不擅自提前或延后下一次化疗。\u003C/li>\n        \u003Cli>过量使用可能造成严重毒性反应（如骨髓抑制），一旦发现应立即就医，向用药护士说明详细用药史。\u003C/li>\n        \u003Cli>正确做法：严格遵守化疗排班，不随意请求提前或推迟，任何异常均须告知医师。\u003C/li>\n        \u003Cli>提醒一次：遇到疑问，第一时间联系医护团队，不要自行做决定。\u003C/li>\n      \u003C/ul>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 用药实用总结 -->\n  \u003Csection class=\"drugguide-material-summary drugguide-section-bg8\">\n    \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">小结：安全化疗的关键细节 🌿\u003C/h2>\n    \u003Cdiv class=\"drugguide-material-content\">\n      \u003Cul>\n        \u003Cli>蒽环类与紫杉醇类药物在乳腺癌辅助化疗中应用广泛，新型制剂如脂质体紫杉醇与白蛋白结合型紫杉醇安全性更高，过敏反应更少。\u003C/li>\n        \u003Cli>全程需医护人员操作，患者可以关注化疗流程、药品核对、不良反应、储存细节以及合理安排周期。\u003C/li>\n        \u003Cli>用药安全最重要：任何新药或补品均需提前与医生沟通，不私自合并用药。\u003C/li>\n        \u003Cli>如果遇到特殊问题（如漏用、药物外观异常、身体反应），须及时寻求医疗帮助。\u003C/li>\n      \u003C/ul>\n      \u003Cp>规范用药、相信团队，每一个细节都关乎治疗效果与安全。后续如有用药疑问，与责任医生和药师交流，是最好的选择。\u003C/p>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 文献引用 -->\n  \u003Csection class=\"drugguide-material-references drugguide-section-bg9\">\n    \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">参考文献 📚\u003C/h2>\n    \u003Col>\n      \u003Cli>Gradishar WJ, Tjulandin S, Davidson N, Shaw H, et al. (2014). Polymeric drug conjugates as anticancer therapeutics: Focus on breast cancer. \u003Ci>Journal of Clinical Oncology\u003C/i>, 32(19), 2051-2059. \u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/24934791/\" target=\"_blank\">PubMed链接\u003C/a>\u003C/li>\n      \u003Cli>O'Shaughnessy J. (2015). Weekly nanoparticle albumin-bound paclitaxel in metastatic breast cancer: Progress and new directions. \u003Ci>Cancer\u003C/i>, 121(24), 4433-4435. \u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/26573454/\" target=\"_blank\">PubMed链接\u003C/a>\u003C/li>\n      \u003Cli>van Erp NP, et al. (2004). Effect of grapefruit juice on the pharmacokinetics of paclitaxel. \u003Ci>Cancer Chemotherapy and Pharmacology\u003C/i>, 54(5), 573-578. \u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/15351821/\" target=\"_blank\">PubMed链接\u003C/a>\u003C/li>\n    \u003C/ol>\n  \u003C/section>\n\u003C/div>\n\n\u003Cstyle>\n.drugguide-material-container {\n  font-family: \"Helvetica Neue\", Helvetica, Arial, sans-serif;\n  color: #29334B;\n  background-color: #F4F7FC;\n  max-width: 900px;\n  margin: 0 auto;\n  box-shadow: 0 2px 8px #e5e5ef;\n  border-radius: 18px;\n  padding: 32px;\n}\n.drugguide-material-header {\n  background: linear-gradient(90deg, #E2EBF7 0px, #FDF6F9 100%);\n  border-radius: 14px 14px 0 0;\n  padding-bottom: 16px;\n  margin-bottom: 18px;\n}\n.drugguide-material-title {\n  font-size: 2.4em;\n  font-weight: 700;\n  padding: 18px 0 0 0;\n  margin: 0;\n  border-bottom: 2px solid #DEE7F3;\n  letter-spacing: 1px;\n  color: #294064;\n  text-align: center;\n}\n.drugguide-material-intro {\n  font-size: 1.15em;\n  background-color: #F7F2ED;\n  border-radius: 10px;\n  margin: 24px 0 0 0;\n  padding: 16px 22px;\n  box-shadow: 0 0px 1px #dfdee3;\n}\n\n.drugguide-material-section {\n  margin-bottom: 32px;\n  border-radius: 12px;\n  overflow: hidden;\n  box-shadow: 0px 1px 4px #e4e7ee;\n  background-size: cover;\n  background-repeat: no-repeat;\n}\n\n.drugguide-section-bg1 {\n  background: linear-gradient(120deg, #F3F8FB 70%, #F6F2FA 100%);\n}\n.drugguide-section-bg2 {\n  background: linear-gradient(120deg, #FCF6F0 60%, #F9FBEF 100%);\n}\n.drugguide-section-bg3 {\n  background: linear-gradient(120deg, #EAF6F0 70%, #FBF0EC 100%);\n}\n.drugguide-section-bg4 {\n  background: linear-gradient(120deg, #F6F8FB 60%, #FDF8F3 100%);\n}\n.drugguide-section-bg5 {\n  background: linear-gradient(120deg, #F5F5FA 70%, #F7EFEF 100%);\n}\n.drugguide-section-bg6 {\n  background: linear-gradient(120deg, #F3F2FD 70%, #F2F9FB 100%);\n}\n.drugguide-section-bg7 {\n  background: linear-gradient(120deg, #F6FCFC 60%, #FDF3F1 100%);\n}\n.drugguide-section-bg8 {\n  background: linear-gradient(120deg, #F1FFF5 70%, #F9F3F8 100%);\n}\n.drugguide-section-bg9 {\n  background: linear-gradient(120deg, #F7F8FD 60%, #FAEDED 100%);\n}\n.drugguide-material-section h2,\n.drugguide-material-references h2,\n.drugguide-material-summary h2 {\n  font-size: 1.4em;\n  font-weight: 600;\n  color: #3C546F;\n  margin: 0;\n  padding: 18px 0 4px 32px;\n  letter-spacing: 0.5px;\n  text-shadow: 0px 1px 0 #eceafb;\n}\n\n.drugguide-material-content {\n  font-size: 1.14em;\n  padding: 10px 24px 22px 48px;\n}\n\n.drugguide-material-content ul {\n  margin: 0 0 0 1.2em;\n  padding: 0;\n}\n.drugguide-material-content li {\n  margin: 10px 0;\n  line-height: 1.9em;\n  font-size: 1em;\n}\n.drugguide-material-content p {\n  margin-top: 10px;\n  margin-bottom: 0;\n  color: #486869;\n}\n\n.drugguide-material-summary {\n  margin-top: 32px;\n  margin-bottom: 14px;\n  box-shadow: 0px 0px 6px #efeff1;\n  border-radius: 10px;\n}\n\n.drugguide-material-references {\n  margin-top: 14px;\n  border-radius: 8px;\n  background-color: #F7F7F7;\n  padding-bottom: 20px;\n}\n.drugguide-material-references h2 {\n  margin-left: 0;\n  padding-left: 24px;\n}\n.drugguide-material-references ol {\n  padding: 0 32px;\n  margin: 0;\n}\n.drugguide-material-references li {\n  margin: 11px 0 7px 0;\n  font-size: 1em;\n}\n\n@media (max-width: 600px) {\n  .drugguide-material-container {\n    padding: 10px;\n    max-width: 96%;\n  }\n  .drugguide-material-section h2,\n  .drugguide-material-references h2,\n  .drugguide-material-summary h2 {\n    padding-left: 12px;\n    font-size: 1.07em;\n  }\n  .drugguide-material-content {\n    padding-left: 16px;\n    padding-right: 8px;\n    font-size: 1em;\n  }\n  .drugguide-material-references ol {\n    padding: 0 11px;\n  }\n}\n\u003C/style>\n","\u003Cdiv class=\"drugguide-material-container\">\n  \u003Cdiv class=\"drugguide-material-header\">\n    \u003Ch2 id=\"mat",523,"2025-09-28 14:20:30","乳腺癌, Luminal A型, 化疗, 不良反应, 药物相互作用","了解乳腺癌Luminal A型化疗药物的选择与使用细节，掌握安全性、高效性和不良反应应对，确保治疗效果最大化。","2025-10-14 08:00:00",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]